Spasmium Comp. 500 mg/ml + 4 mg/ml Solution for Injection United Kingdom - English - VMD (Veterinary Medicines Directorate)

spasmium comp. 500 mg/ml + 4 mg/ml solution for injection

richter pharma ag - hyoscine butylbromide, metamizole sodium monohydrate - solution for injection - neurological agent muscle relaxant - cattle, dogs, horses, pigs

Sympagesic 500 mg/ml + 4 mg/ml Solution for Injection for Horses, Cattle, Pigs and Dogs United Kingdom - English - VMD (Veterinary Medicines Directorate)

sympagesic 500 mg/ml + 4 mg/ml solution for injection for horses, cattle, pigs and dogs

dechra regulatory bv - hyoscine butylbromide, metamizole sodium monohydrate - solution for injection - neurological agent muscle relaxant - cattle, dogs, horses, pigs

Spasmium Comp. 500 mg/ml + 4 mg/ml Solution for Injection United Kingdom - English - VMD (Veterinary Medicines Directorate)

spasmium comp. 500 mg/ml + 4 mg/ml solution for injection

vetviva richter gmbh - hyoscine butylbromide, metamizole sodium monohydrate - solution for injection - neurological agent muscle relaxant - cattle, dogs, horses, pigs

OPTALGIN DROPS Israel - English - Ministry of Health

optalgin drops

teva pharmaceutical industries ltd, israel - dipyrone - drops - dipyrone 500 mg/ml - metamizole sodium - metamizole sodium - relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.

Buscopan Compositum ad us. vet 500 mg/ml - 4 mg/ml inj. sol. i.v./s.c. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

buscopan compositum ad us. vet 500 mg/ml - 4 mg/ml inj. sol. i.v./s.c. vial

boehringer ingelheim vetmedica gmbh - butylhyoscine bromide 4 mg/ml - eq. butylhyoscine 32,743 mg/ml; metamizole sodium 500 mg/ml - solution for injection - 500 mg/ml - 4 mg/ml - butylhyoscine bromide 4 mg/ml; metamizole sodium 500 mg/ml - butylscopolamine - cattle; dog; horse

Valproate-AFT New Zealand - English - Medsafe (Medicines Safety Authority)

valproate-aft

aft pharmaceuticals ltd - sodium valproate 100 mg/ml - solution for injection - 100 mg/ml - active: sodium valproate 100 mg/ml excipient: dibasic sodium phosphate dodecahydrate monobasic potassium phosphate water for injection - the treatment of patients with epilepsy or bipolar disorder, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

Epilim 100 mg Crushable Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

epilim 100 mg crushable tablets

sanofi-aventis ireland limited t/a sanofi - sodium valproate - tablet - 100 milligram(s) - fatty acid derivatives; valproic acid

Epilim Chrono 200mg Prolonged Release Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

epilim chrono 200mg prolonged release tablets

sanofi-aventis ireland limited t/a sanofi - sodium valproate; valproic acid - prolonged-release tablet - 200 milligram(s) - fatty acid derivatives; valproic acid

Epilim Chrono 300mg Prolonged Release Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

epilim chrono 300mg prolonged release tablets

sanofi-aventis ireland limited t/a sanofi - sodium valproate; valproic acid - prolonged-release tablet - 300 milligram(s) - fatty acid derivatives; valproic acid

Epilim Chrono 500mg Prolonged Release Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

epilim chrono 500mg prolonged release tablets

sanofi-aventis ireland limited t/a sanofi - sodium valproate; valproic acid - prolonged-release tablet - 500 milligram(s) - fatty acid derivatives; valproic acid